Fmr Union Min Suresh Prabhu urges Sadananda Gowda to regulate prices, supply of Mucormycosis medicine
PTI, May 11, 2021, 2:25 PM IST
New Delhi: Former Union Minister Suresh Prabhu on Tuesday urged Chemicals and Fertilisers Minister Sadananda Gowda to regulate the prices and supply of medicine used in the treatment of Mucormycosis, a fungal infection, to ensure that no artificial shortage is created.
In a letter to Gowda, he said that it has been noticed that pharmaceutical companies have raised the prices of Amphotercin, a drug used in the management of this infection and shortage of this medicine has also been reported.
“I would request your urgent intervention in this matter to regulate the prices and supply of the medicine for this deadly Mucormycosis infection to ensure that no artificial shortage is created,” Prabhu said.
He added that there has been an increase in the cases of this disease.
Niti Aayog Member (Health) V K Paul on Friday said Mucormycosis, a fungal infection, is being found in COVID-19 patients and largely in cases of those who are diabetic.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Balasore tragedy result of composite negligence of railway officials: Orissa High Court
Three convicted for 2016 Kollam collectorate blast case
Expect Canadian government to ensure justice, uphold rule of law: PM Modi
Group clash in Indore after argument over bursting firecrackers: NSA slapped against 2 accused
Police rescue 70 cattle after gunfight with cow smugglers in Rajasthan’s Bharatpur
MUST WATCH
Latest Additions
Balasore tragedy result of composite negligence of railway officials: Orissa High Court
Actress Kasthuri stokes controversy by her remarks on Telugu-speaking people in TN
Three convicted for 2016 Kollam collectorate blast case
Expect Canadian government to ensure justice, uphold rule of law: PM Modi
Group clash in Indore after argument over bursting firecrackers: NSA slapped against 2 accused
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.